ATE539756T1 - Prostaglandinsubstanzen für die behandlung von fettsucht - Google Patents

Prostaglandinsubstanzen für die behandlung von fettsucht

Info

Publication number
ATE539756T1
ATE539756T1 AT03758747T AT03758747T ATE539756T1 AT E539756 T1 ATE539756 T1 AT E539756T1 AT 03758747 T AT03758747 T AT 03758747T AT 03758747 T AT03758747 T AT 03758747T AT E539756 T1 ATE539756 T1 AT E539756T1
Authority
AT
Austria
Prior art keywords
obesity
prostagland
substances
treatment
compound
Prior art date
Application number
AT03758747T
Other languages
German (de)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of ATE539756T1 publication Critical patent/ATE539756T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03758747T 2002-10-23 2003-10-22 Prostaglandinsubstanzen für die behandlung von fettsucht ATE539756T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42033602P 2002-10-23 2002-10-23
PCT/JP2003/013453 WO2004037268A1 (en) 2002-10-23 2003-10-22 Prostaglandin compounds for the treatment of obesity

Publications (1)

Publication Number Publication Date
ATE539756T1 true ATE539756T1 (de) 2012-01-15

Family

ID=32176556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758747T ATE539756T1 (de) 2002-10-23 2003-10-22 Prostaglandinsubstanzen für die behandlung von fettsucht

Country Status (11)

Country Link
US (1) US8114911B2 (enExample)
EP (1) EP1562604B1 (enExample)
JP (1) JP4705782B2 (enExample)
AT (1) ATE539756T1 (enExample)
AU (1) AU2003274735B2 (enExample)
CA (1) CA2502439C (enExample)
DK (1) DK1562604T3 (enExample)
ES (1) ES2379652T3 (enExample)
NZ (1) NZ539582A (enExample)
PT (1) PT1562604E (enExample)
WO (1) WO2004037268A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337891B2 (en) 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
CA2824317C (en) 2011-01-19 2014-12-16 Terakine Therapeutics, Inc. Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
KR101651448B1 (ko) 2012-11-21 2016-08-26 토포카인 쎄라퓨틱스, 인코포레이티드 체지방을 국소적으로 증가시키는 방법 및 조성물
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
US20140308354A1 (en) 2013-04-12 2014-10-16 Allergan, Inc. Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
NO2753788T3 (enExample) 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
US10188661B2 (en) 2014-06-27 2019-01-29 Topokine Therapeutics, Inc. Topical dosage regimen
US11452703B2 (en) 2020-05-21 2022-09-27 Peregrine Ophthalmic PTE LTD. Methods and compositions for reducing adipocyte numbers

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US388919A (en) * 1888-09-04 Benjamin scables
US3888919A (en) * 1971-03-11 1975-06-10 Upjohn Co 11,15 dimethyl pge' 1 'and pgf' 1'
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
NZ226198A (en) * 1988-09-15 1991-05-28 Ueno Seiyaku Oyo Kenkyujo Kk Fervescence (temperature raising) composition comprising 15-keto-pge
NZ226199A (en) * 1988-09-15 1991-05-28 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-pgf derivatives and pharmaceutical compositions
DE69006964T2 (de) * 1989-07-27 1994-06-09 Ueno Seiyaku Oyo Kenkyujo Kk Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
JPH085794B2 (ja) * 1989-07-27 1996-01-24 株式会社上野製薬応用研究所 高脂質血症処置・血中脂質成分低下剤
TW224942B (enExample) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US6022897A (en) * 1995-04-25 2000-02-08 The Salk Institute For Biological Studies Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
US6242485B1 (en) * 1996-06-10 2001-06-05 R-Tech Ueno Endothelin antagonist
EP1071429B1 (en) * 1998-04-17 2002-01-30 Trustees Of Tufts College Map kinase inhibitors in the treatment of disorders caused by tnf-alpha induced lipolysis
JP2000157260A (ja) * 1998-11-26 2000-06-13 Toyobo Co Ltd 初代前駆脂肪細胞の分化誘導方法及びその分化用培地
DE60039727D1 (de) * 1999-10-15 2008-09-11 Sucampo Ag Neue Zusammensetzung enthaltend eine bicyclische Verbindung und ein Glycerid
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
AU2002330747B2 (en) * 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
AU2003292556B2 (en) * 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
EP1871380B1 (en) * 2005-04-12 2011-10-19 Sucampo AG Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
CA2502439A1 (en) 2004-05-06
EP1562604A1 (en) 2005-08-17
EP1562604B1 (en) 2012-01-04
JP4705782B2 (ja) 2011-06-22
DK1562604T3 (da) 2012-04-02
WO2004037268A1 (en) 2004-05-06
AU2003274735B2 (en) 2008-12-04
ES2379652T3 (es) 2012-04-30
US20050261373A1 (en) 2005-11-24
NZ539582A (en) 2007-07-27
JP2006506381A (ja) 2006-02-23
PT1562604E (pt) 2012-04-09
AU2003274735A1 (en) 2004-05-13
CA2502439C (en) 2011-11-22
US8114911B2 (en) 2012-02-14

Similar Documents

Publication Publication Date Title
ATE368031T1 (de) Neue gamma secretase inhibitoren
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
ATE433447T1 (de) Pyrimiidinverbindungen
NO20070606L (no) Inhibitorer av IAP
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
YU5503A (sh) Nesteroidni supresori zapaljenja
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
TW200517377A (en) New 2-pyridinylethylbenzamide compounds
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE411287T1 (de) Neue metallproteinaseinhibitoren
ATE502631T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DE60327432D1 (de) Nützliche verbindungen für die behandlung von anthrax und hemmung des letalen faktors
ATE443044T1 (de) Tace inhibitoren
DK1562604T3 (da) Prostaglandinforbindelser til behandling af fedme
BRPI0415678A (pt) compostos de pirimidina para o tratamento de inflamação
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
EA200601106A1 (ru) Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции
BR0214445B1 (pt) processos para a produção de compostos.
DK1353660T3 (da) Anvendelse af substituerede 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens